<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03780985</url>
  </required_header>
  <id_info>
    <org_study_id>IUD-Zahraa</org_study_id>
    <nct_id>NCT03780985</nct_id>
  </id_info>
  <brief_title>Post-placental Intrauterine Device Insertion During Cesarean Section</brief_title>
  <official_title>Hang-up Versus Non-fixation Technique for Immediate Post-placental Intrauterine Device Insertion During Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effective, reversible postpartum contraception decreases the chance of rapid repeat pregnancy
      and poor perinatal outcome in a subsequent pregnancy especially in women delivered by
      cesarean section.The traditional 6-week postpartum visits not evidenced based and may not
      meet patient needs, particularly with respect to provision of contraception.Intrauterine
      device placement after delivery of the placenta is an appealing strategy for increasing
      access to postpartum Intrauterine device because it does not require a separate postpartum
      visit.

      Advantage of post-placental Intrauterine device insertion, Intrauterine devices are
      recommended as first-line contraceptives by the American Academy of Pediatricians. The
      Centers for Disease Control and Prevention united state . Medical Eligibility Criteria for
      Contraceptive Use places no restrictions on use, and states advantages generally outweigh the
      risks for immediate postpartum use of Intrauterine devices.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of displaced intrauterine device after insertion in both groups</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Intrauterine Device Insertion Complication</condition>
  <arm_group>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IUD through hysterotomy incision during cesarean section with a suture fixation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IUD through hysterotomy incision during cesarean section without a suture fixation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrauterine device insertion</intervention_name>
    <description>Post-placental insertion of intrauterine device during Cesarean section</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cesarean section</intervention_name>
    <description>to delivery of the fetus</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
    <arm_group_label>intrauterine device insertion without a suture fixation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suture</intervention_name>
    <description>to fix the intrauterine device</description>
    <arm_group_label>intrauterine device insertion with a suture fixation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age group : 18-40 years

          2. Women who will be willing to undergo elective cesarean section

          3. women desire using Copper IUD as long acting contraceptive method.

        Exclusion Criteria:

          1. Intrauterine infection.

          2. Fundal Myoma.

          3. Hemorrhagic disorder

          4. Genital tract malignancy

          5. Uterine atony

          6. Sexually transmitted infection.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 18, 2018</study_first_submitted>
  <study_first_submitted_qc>December 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2018</study_first_posted>
  <last_update_submitted>December 18, 2018</last_update_submitted>
  <last_update_submitted_qc>December 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

